Continuation of the Prescription Drug Event (PDE) Reports
and PDE Analysis Reporting Initiatives for the 2016
Benefit Year
Guidance for: The purpose of this memorandum is to announce the continuation of two reporting initiatives for the 2016 benefit
year that support CMS’s efforts to improve the accuracy of sponsors’ PDE data.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 12, 2016
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.